Overview of Dr. Mahtani
Dr. Reshma Mahtani is an oncologist in Miami, FL and is affiliated with Baptist Hospital of Miami. She received her medical degree from University of New England College of Osteopathic Medicine and has been in practice 16 years. Dr. Mahtani accepts several types of health insurance, listed below. She is one of 58 doctors at Baptist Hospital of Miami who specialize in Oncology. She has more than 40 publications and over 500 citings.
Office
Baptist Health Miami Cancer Institute
8900 N Kendall Dr
Miami, FL 33176
Education & Training
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007- Westchester Medical CenterResidency, Internal Medicine, 2002 - 2004
Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2001 - 2002
University of New England College of Osteopathic MedicineClass of 2001
Certifications & Licensure
FL State License 2007 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer Start of enrollment: 2008 Oct 21
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsA retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.Tadeu Ambros, Simon B. Zeichner, John Zaravinos, Alberto J. Montero, Eugene Ahn
Breast Cancer Research and Treatment. 2014-06-05 - 16 citationsBRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breas...Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar
Journal of Clinical Oncology. 2022-02-01 - 7 citationsClinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US:Ran Jin, Reshma Mahtani, Neil A. Accortt, Tatiana Lawrence, Darcie Sandschafer
Therapeutic Advances in Medical Oncology. 2021-09-01
Journal Articles
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerRita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
Authored Content
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020
Press Mentions
Biomarker Testing Best Practices in NSCLCJuly 31st, 2024- What to Know About Enhertu, the First Targeted Treatment for HER2-Low Breast CancerAugust 24th, 2022
- Reshma Mahtani, DO, Joins MCI as Chief of Breast Medical OncologyFebruary 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United - River Valley Neighborhood Health Partnership
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
